| 15 Swedish bio-researchers possess elements of $ 400 million |
|
|
|
 Picture of cell death by Elias Arner research now supported by the SSF. Using proteins as biomarkers, researchers can, for example, show where in the body increased cell death exists. This picture shows an increased uptake of a protein that indicates cell death in a cancer tumor (T) as well as in liver (L) after 20-28 hours of cancer treatment. Click to see the whole picture.
Foundation for Strategic Research SSF makes its largest research effort in several years when you invest 400 million kronor to 15 researchers in four major areas. 1. Fighting anti bio-tikarestisten. 2nd The development of biomarkers and model systems at an early statdium be able to help researchers to assess the potential of new drug candidates. 3rd Increased understanding of the importance of the environment for gene effects on health, 4th Development method to combat mold and other pests that attack trees and crops,  Lars Rask, President and CEO of SSF. - We face significant challenges ahead in the medical field. It is of great strategic importance to more players than the pharmaceutical industry invests resources into basic research in these areas, "said SSF's CEO Lars Rask in a statement in connection with the research effort became public on Thursday. Lars Rask is critical to the pharmaceutical industry does not invest in basic research and early development of new drugs to the same extent as before. - It is probably because many development projects fail to lead to commercial solutions, and that profitability is far too insecure in comparison with a continued focus on the development of already established drugs, "he says. There are fifteen named scientists who will share 400 million crowns in four years. The highest individual sum is 35 million and the lowest is 20. Over the past 15 years, SSF has distributed more than SEK 10 billion for research. - SSF has become known for having a bit more daring research, "says Lars Rask. |
| < Prev | Next > |
|---|
